339 related articles for article (PubMed ID: 17589924)
41. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
[TBL] [Abstract][Full Text] [Related]
42. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
[TBL] [Abstract][Full Text] [Related]
43. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
[TBL] [Abstract][Full Text] [Related]
44. Comparison of two recombinant hepatitis B vaccines and their interchangeability in Argentine infants.
Tregnaghi M; Ussher J; Baudagna AM; Calvari M; Graña G
Rev Panam Salud Publica; 2004 Jan; 15(1):35-40. PubMed ID: 14987456
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis B vaccination in preterm infants.
Gołebiowska M; Kardas-Sobantka D; Chlebna-Sokół D; Sabanty W
Eur J Pediatr; 1999 Apr; 158(4):293-7. PubMed ID: 10206126
[TBL] [Abstract][Full Text] [Related]
46. Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
Lee AW; Vesikari T; Gilbert CL; Klopfer SO; Schödel FP; Bhuyan PK
Vaccine; 2011 Oct; 29(45):7942-8. PubMed ID: 21875633
[TBL] [Abstract][Full Text] [Related]
47. Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age.
Greenberg DP; Vadheim CM; Wong VK; Marcy SM; Partridge S; Greene T; Chiu CY; Margolis HS; Ward JI
Pediatr Infect Dis J; 1996 Jul; 15(7):590-6. PubMed ID: 8823852
[TBL] [Abstract][Full Text] [Related]
48. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates.
del Canho R; Grosheide PM; Schalm SW; de Vries RR; Heijtink RA
J Hepatol; 1994 Apr; 20(4):483-6. PubMed ID: 8051386
[TBL] [Abstract][Full Text] [Related]
49. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.
Baldy JL; de Lima GZ; Morimoto HK; Reiche EM; Matsuo T; de Mattos ED; Sudan LC
Rev Inst Med Trop Sao Paulo; 2004; 46(2):103-7. PubMed ID: 15141282
[TBL] [Abstract][Full Text] [Related]
50. Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults.
Wang H; Cai B; Rao D; Liu M; Li Y; Liang X; Cui F; Zhang G; Wang F; Pang X; Nie L; Qiu Q; Wu J; Li L; Huang F; Zhang W
Hum Vaccin Immunother; 2016 Nov; 12(11):2921-2926. PubMed ID: 27648684
[TBL] [Abstract][Full Text] [Related]
51. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
[TBL] [Abstract][Full Text] [Related]
52. Response to challenge dose among young adults vaccinated for hepatitis B as infants: importance of detectable residual antibody to hepatitis B surface antigen.
Spradling PR; Kamili S; Xing J; Drobeniuc J; Hu DJ; Middleman AB
Infect Control Hosp Epidemiol; 2015 May; 36(5):529-33. PubMed ID: 25643863
[TBL] [Abstract][Full Text] [Related]
53. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
Chow KM; Law MC; Leung CB; Szeto CC; Li PK
Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1988 Dec; 6(2):107-10. PubMed ID: 2975491
[TBL] [Abstract][Full Text] [Related]
55. Comparison study of the immunogenicity and safety of 5- and 10-microgram dosages of a recombinant hepatitis B vaccine in healthy infants.
Goldfarb J; Medendorp SV; Garcia H; Nagamori K; Rathfon H; Krause D
Pediatr Infect Dis J; 1996 Sep; 15(9):764-7. PubMed ID: 8878217
[TBL] [Abstract][Full Text] [Related]
56. Duration of protection after infant hepatitis B vaccination series.
Middleman AB; Baker CJ; Kozinetz CA; Kamili S; Nguyen C; Hu DJ; Spradling PR
Pediatrics; 2014 Jun; 133(6):e1500-7. PubMed ID: 24843060
[TBL] [Abstract][Full Text] [Related]
57. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis.
Onuigbo MA; Nesbit A; Weisenbeck J; Hurlburt J
Ren Fail; 2010 May; 32(4):531-2. PubMed ID: 20446799
[TBL] [Abstract][Full Text] [Related]
59. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
[No Abstract] [Full Text] [Related]
60. [Effectiveness of rapid hepatitis B vaccination with different vaccine dosages and types in adults].
Nie L; Pang XH; Zhang Z; Ma JX; Liu XY; Qiu Q; Liang Y; Li Q; Zhang W
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1151-1155. PubMed ID: 28910921
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
